Gastrointestinal Cancer News

A pain-assessment tool with built-in treatment guidance reduced cancer-related pain outcomes, according to study data.

April is National Cancer Control Month.

Disease recurrence occurs significantly later for patients with gastroenteropancreatic neuroendocrine tumors compared with other gastrointestinal cancers, according to a research letter published in JAMA Oncology.

Metastatic cancer cells originating from colorectal cancer can reprogram their metabolism to create an enzyme that feeds on fructose in the liver, which increases proliferation, according to a recently published study.

Dasatinib demonstrated antitumor activity among a subset of patients with imatinib-resistant gastrointestinal stromal tumors, according to results of a nonrandomized, open-label, single-arm trial published in JAMA Oncology.

Johns Hopkins Kimmel Cancer Center researchers have developed a blood test designed to screen for the eight most common cancer types.

Only two-thirds of Americans aged 50 to 75 years are up to date with colorectal cancer screening.

This year’s American Association for Cancer Research Annual Meeting featured several potentially practice-changing studies, including many that evaluated novel immunotherapy regimens and assessed biomarkers that may predict treatment response.

Alcohol consumption correlated with significant changes to the oral microbiome that have been previously linked to alcohol-related diseases like periodontal disease, GI cancers, head and neck cancers and heart disease, according to new research published in the journal Microbiome.

A one-time sigmoidoscopy screening reduced colorectal cancer incidence and mortality in men, though little or no effect was observed in women, according to a Norwegian study published today in Annals of Internal Medicine.